Physician profile
Cory Lee Simpson
NPI 1134474356
$11,609.66
in general payments reported to CMS, 2019-2025
5 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,500 · 2023: $2,100 · 2024: $7,605 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,705 · Honoraria: $300 · Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,705.00 |
| Honoraria | $300.00 |
| Food and Beverage | $104.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $7,605.00 | 2024 | |
| Argenx US, INC. | $3,600.00 | 2022-2023 | Vyvgart |
| Chiesi USA, INC. | $300.00 | 2025 | Filsuvez |
| Tactile Systems Technology INC | $71.50 | 2025 | Flexitouch Plus, Nimbl |
| Leo Pharma INC. | $33.16 | 2025 | Spevigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.